CRP and colorectal carcinoma: Higher concentrations of the inflammatory biomarker C-reactive protein (CRP) have been associated with a moderately higher risk of colorectal cancer (CRC) in a meta-analysis of eighteen prospective studies [8], although significant heterogeneity was observed across individual studies.